Anterior and posterior capsulorhexis in children

Article

Anterior and posterior capsulorhexis in children

Refractive surgery in children should be limited to those who have no alternative, Professor Michael O’Keefe, head of paediatric ophthalmology in University College, Dublin, told delegates yesterday.

“To improve or prevent amblyopia it must be performed early. It is not a substitute for patching,” he declared, concluding, ”We have learned a lot from adult refractive surgery. It is safe to apply some of this to paediatric refractive surgery.”

He explained that surgery is not commonly performed in paediatric patients. In the published literature between LASIK,LASEK and intraocular lenses there are less than 500 children treated.

“There are many reasons for this. The paediatric eye is different, with ocular growth to the mid teens, the sclera and cornea are less rigid and the visual system is developing. ”

He said there are are specific problems, too, such as anaesthesia, pre operative work up, exposure, the appropriate type of surgery and the post operative care. “There are not the same commercial drivers as there are only a handful of indications such as bilateral high myopia, anisometropia, accommodative strabismus and children who have undergone previous cataract surgery.”He said that most criticism of refractive surgery in children reflected the quality of published studies.

Published studies are retrospective or of dubious prospective nature, numbers studied are small and the follow up short. Some of the claims, such as restoration of stereopsis or improvement in amblyopia, lack scientific credibility. “It is not possible to restore any sort of improved vision or stereopsis when the child is beyond the age of cortical visual maturity,” Prof. O’Keefe, stated. He also noted that paediatric ophthalmologists tended to the other extreme, being more critical.

O'Keefe summarised refractive technique, namely LASIK versus LASEK.“I've experience of both procedures. In the LASIK group published in BJO (2004) we encountered no surgical complications. They all needed general anaesthesia. Those who had early refractive surgery got improved vision with patching and those who had late refractive surgery did not improve,” he said. Also, there are more numbers of children who have LASEK performed than LASIK because it is safer with less risk of flap displacement due to eye rubbing, common in children.

Pain is not as much a problem in children as in adults, he said. Regression remains the major issue because many have large refractive errors with high risk of keratocytes mediated re growth and epithelial hyperplasia .

“Papesse in a long term study 2004 reported a 33% regression over 3 years. So these children need Mitomycin and steroids post surgery. The mere thought of using these agents is likely to excite many paediatric ophthalmologists,“he told delegates.

He concluded that paediatric refractive surgery has a role but must be deployed with care.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.